A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

NCT02703051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: GMI-1271
DRUG: Filgrastim
DRUG: Placebo Injection
DRUG: Placebo Infusion

Sponsor

GlycoMimetics Incorporated

Collaborators

[object Object]